This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Johns Hopkins University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Jing Xu - Innovator in Angiogenesis Inhibition
Introduction
Jing Xu is a notable inventor based in Parkville, MD (US). He has made significant contributions to the field of medical research, particularly in the area of angiogenesis inhibition. His work focuses on developing innovative methods to treat and prevent disorders associated with angiogenesis.
Latest Patents
Jing Xu holds a patent for "Chirally pure isomers of itraconazole for use as angiogenesis inhibitors." This patent describes methods of inhibiting angiogenesis and outlines the administration of anti-angiogenesis compounds to a subject. His innovative approach has the potential to impact various medical conditions linked to abnormal blood vessel growth.
Career Highlights
Jing Xu is affiliated with Johns Hopkins University, where he conducts his research and development. His work at this prestigious institution has allowed him to explore groundbreaking ideas and contribute to advancements in medical science.
Collaborations
Jing Xu has collaborated with esteemed colleagues Wie Shi and Jun Lu. Their combined expertise enhances the research efforts and fosters a collaborative environment that drives innovation.
Conclusion
Jing Xu's contributions to the field of angiogenesis inhibition through his patent and research at Johns Hopkins University highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile